logo


Alpharma Announces Information for Third Quarter 2008 Earnings Conference Call
Friday, October 24, 2008 4:05 PM


BRIDGEWATER, NJ -- (Marketwire) -- 10/24/08 -- Alpharma Inc. (NYSE: ALO) announced that the company will release its third quarter 2008 earnings before the market opens on Wednesday, October 29, 2008. Alpharma's management will conduct a conference call / webcast on Wednesday, October 29, beginning at 8:30 AM Eastern Daylight Time, solely to discuss its third quarter results and full year outlook. The presentation which management will refer to on the call will be available on the Company's website in the "Investor's Support" section at www.alpharma.com.

The call will be open to all interested parties and may be accessed by using the following information:

                        CONFERENCE CALL ACCESS
                        ----------------------
                Domestic Dial In:         (800) 351-4892
                International Dial In:    (334) 323-7224
                Conference Call ID:       ALPHARMA

Investors can access the call in a "listen only" mode via the Internet at http://www.streetevents.com.

In addition, for those unable to participate at the time of the call, a rebroadcast will be available following the call from Wednesday, October 29, 2008 at 12:00 PM Eastern Daylight Time until Wednesday, November 12, 2008 Eastern Standard Time at midnight. The rebroadcast may be accessed on the Internet at http://www.streetevents.com or by telephone using the following information:

                           REBROADCAST ACCESS
                           ------------------
                Domestic Dial In:         (877) 919-4059
                International Dial In:    (334) 323-7226
                Participant Code:         47429233

About Alpharma

Alpharma Inc. (NYSE: ALO) is a global specialty pharmaceutical company with leadership positions in products for humans and animals. Alpharma is presently active in more than 80 countries. Alpharma has a growing branded pharmaceutical franchise in the U.S. pain market with its KADIAN® (morphine sulfate extended-release) Capsules, and the FLECTOR® Patch (diclofenac epolamine topical patch) 1.3%. Alpharma is also internationally recognized as a leading provider of pharmaceutical products for poultry and livestock.

Alpharma press releases are also available at our website. www.alpharma.com.

Contact:
Jack Howarth
Vice President, Investor Relations
908-566-4153
Email Contact

(Source: Market Wire )


(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

  
Related Press Releases
Advertisement
Popular Articles
Advertisement
Partner Center
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia